Literature DB >> 3031145

Adrenocortical responsiveness to the ACTH stimulation test in depressed patients and healthy volunteers.

J D Amsterdam, G Maislin, E Abelman, N Berwish, A Winokur.   

Abstract

Adrenocortical activation in depression has been postulated to result from overactivity of limbic system-hypothalamic function. However, some studies suggest the possibility that excessive secretion of cortisol might result, in part, from a heightened adrenocortical responsiveness to ACTH. To further examine this possibility, we utilized both the ACTH stimulation test and the overnight dexamethasone suppression test (DST) in 72 patients with major depression and 37 age- and gender-matched healthy volunteers. The melancholic/DST-nonsuppressor group had larger mean peak cortisol and cumulative cortisol responses (CCR) than any of the other patients groups or healthy controls. However, the differences failed to reach statistical significance as a result of a relatively large cortisol response variability. Nevertheless, the present findings are in general agreement with previous reports suggesting the possibility of an enhanced adrenocortical responsiveness to ACTH.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3031145     DOI: 10.1016/0165-0327(86)90078-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

1.  Depression and hip fracture risk: the NHANES I epidemiologic follow-up study.

Authors:  Michael E Mussolino
Journal:  Public Health Rep       Date:  2005 Jan-Feb       Impact factor: 2.792

2.  Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis.

Authors:  Ivar Tjernberg; Martin Carlsson; Jan Ernerudh; Ingvar Eliasson; Pia Forsberg
Journal:  BMC Infect Dis       Date:  2010-02-05       Impact factor: 3.090

3.  Cortisol and Dehydroepiandrosterone Response to Adrenocorticotropic Hormone and Frailty in Older Women.

Authors:  Nina P Le; Ravi Varadhan; Linda P Fried; Anne R Cappola
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-04-30       Impact factor: 6.053

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.